Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Gland Pharma Ltd. ( (IN:GLAND) ) just unveiled an announcement.
Gland Pharma Limited has announced a series of scheduled interactions with analysts and institutional investors in early February 2026, in line with its disclosure obligations under Indian securities regulations. The company will participate in a non-deal roadshow with Motilal Oswal on 4 February, followed by one-on-one and group meetings at the JM Financial India Xchange Conference on 5 February, and further engagements at the Systematix India Annual Conference on 9 February and Axis Capital’s Flagship India Conference on 10 February. These meetings, which may be subject to change due to logistical exigencies, underscore Gland Pharma’s ongoing efforts to engage the investment community, enhance transparency, and potentially reinforce market confidence through direct interaction with key capital market stakeholders.
More about Gland Pharma Ltd.
Gland Pharma Limited is an India-based pharmaceutical company focused on the development and manufacturing of injectable formulations. It supplies products to regulated markets and serves both domestic and international customers in the healthcare and hospital segments.
Average Trading Volume: 17,290
Technical Sentiment Signal: Buy
Current Market Cap: 304.1B INR
See more insights into GLAND stock on TipRanks’ Stock Analysis page.